FPHAX
Fidelity Select Pharmaceuticals
1W: -1.2%
1M: -9.6%
3M: -5.8%
YTD: -2.3%
1Y: +18.1%
3Y: +58.4%
5Y: +71.0%
$30.88
+0.67 (+2.22%)
ETF-Level Metrics
AUM$1.1B
Holdings36
Top 10 Wt79.4%
Beta0.73
% Profitable19%
Coverage91%
Portfolio Valuation
P/E15.3
P/B7.6
P/S4.6
EV/EBITDA14.7
P/FCF27.0
PEG0.30
Profitability & Returns
Gross Margin82.0%
Net Margin30.0%
ROE57.1%
ROA18.2%
ROIC31.2%
Div Yield1.42%
Leverage & Liquidity
Debt/Equity0.86
Debt/Assets0.29
Net Debt/EBITDA0.9x
Interest Cov20.9x
Current Ratio1.04
Quick Ratio0.77
Growth (YoY)
Revenue+20.9%
Net Income+43.1%
EPS+66.6%
FCF+71.6%
EBITDA+27.6%
Rev CAGR 3Y+20.9%
Quality Scores
Piotroski F6.6
Altman Z9.68
IS Quality73.3
IS Overall60.7
IS Value46.9
Median P/E-7.2
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 36 | 98.6% | -4.0 |
| Other | 17 | 2.2% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 4.92% | 4 | Bullish | 11 | 2 | +0.9% |
Showing 50 of 53 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY and CO | LLY | 26.95% | $291.0M | 397,261 | 39.9 | $865.9B | Healthcare |
| 2 | ASTRAZENECA PLC | AZN | 10.81% | $116.7M | 1,460,800 | 28.1 | $145.1B | Healthcare |
| 3 | NOVO-NORDISK AS | NVO | 10.79% | $116.5M | 2,063,000 | 10.2 | $161.5B | Healthcare |
| 4 | UCB SA | UCB.BR | 5.07% | $46.8M | 234,100 | 31.0 | $48.3B | Healthcare |
| 5 | GSK PLC | GSK | 4.93% | $53.3M | 1,342,860 | 14.4 | $110.5B | Healthcare |
| 6 | MERCK and CO INC | MRK | 4.92% | $53.1M | 631,436 | 16.3 | $295.1B | Healthcare |
| 7 | GILEAD SCIENCES INC | GILD.SW | 4.36% | $47.1M | 416,900 | — | $142.5B | Healthcare |
| 8 | ELANCO ANIMAL HEALTH INC | ELAN | 4.30% | $46.4M | 2,531,100 | -54.6 | $12.7B | Healthcare |
| 9 | ROYALTY PHARMA PLC | RPRX | 3.87% | $41.7M | 1,160,000 | 26.3 | $20.1B | Healthcare |
| 10 | AVIDITY BIOSCIENCES INC | RNAM | 3.42% | $37.0M | 793,500 | — | $11.3B | Healthcare |
| 11 | LEGEND BIOTECH CORP | LEGN | 2.68% | $28.9M | 832,700 | -10.9 | $3.3B | Healthcare |
| 12 | FINANCIERE DE TUBIZE SA | TUB.BR | 2.44% | $22.6M | 141,200 | 101.5 | $9.5B | Healthcare |
| 13 | OCULAR THERAPEUTIX INC | OCUL | 1.48% | $16.0M | 1,306,417 | -7.0 | $1.8B | Healthcare |
| 14 | Fidelity Revere Street Trust Private | — | 1.20% | $13.0M | 12,994,526 | — | — | — |
| 15 | XENON PHARMACEUTICALS INC | XENE | 1.02% | $11.0M | 284,300 | -12.7 | $4.6B | Healthcare |
| 16 | BIONTECH SE | BNTX | 0.97% | $10.5M | 104,553 | -16.7 | $22.3B | Healthcare |
| 17 | MODERNA INC | MRNA | 0.93% | $10.1M | 417,600 | -7.4 | $21.1B | Healthcare |
| 18 | METSERA INC | MTSR | 0.91% | $9.8M | 278,676 | -23.6 | $7.4B | Healthcare |
| 19 | ARCUS BIOSCIENCES INC | RCUS | 0.84% | $9.0M | 853,517 | -6.5 | $2.2B | Healthcare |
| 20 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 0.71% | $7.6M | 254,500 | -3.4 | $1.9B | Healthcare |
| 21 | PTC THERAPEUTICS INC | PTCT | 0.69% | $7.4M | 150,800 | 7.9 | $5.5B | Healthcare |
| 22 | JAZZ PHARMACEUTICALS PLC | JAZZ | 0.68% | $7.3M | 57,100 | -32.4 | $11.6B | Healthcare |
| 23 | DISC MEDICINE INC | IRON | 0.66% | $7.1M | 118,900 | -10.4 | $2.4B | Healthcare |
| 24 | ASCENDIS PHARMA A/S | ASND | 0.65% | $7.0M | 36,100 | -51.5 | $13.6B | Healthcare |
| 25 | INSMED INC | INSM | 0.61% | $6.6M | 48,200 | -24.8 | $32.0B | Healthcare |
| 26 | MERUS NV | MRUS | 0.55% | $6.0M | 90,400 | -19.5 | $6.8B | Healthcare |
| 27 | AXSOME THERAPEUTICS INC | AXSM | 0.55% | $5.9M | 48,900 | -44.7 | $8.3B | Healthcare |
| 28 | UNIQURE N.V. | 0EE0.L | 0.54% | $5.8M | 358,100 | -4.7 | $941M | Healthcare |
| 29 | INTELLIA THERAPEUTICS INC | NTLA | 0.50% | $5.4M | 472,500 | -3.5 | $1.6B | Healthcare |
| 30 | BEAM THERAPEUTICS INC | BEAM | 0.36% | $3.9M | 239,700 | -29.7 | $2.4B | Healthcare |
| 31 | CRINETICS PHARMACEUTICALS INC | CRNX | 0.35% | $3.8M | 122,800 | -7.3 | $3.8B | Healthcare |
| 32 | HARMONY BIOSCIENCES HOLDINGS INC | HRMY | 0.32% | $3.5M | 93,877 | 10.0 | $1.6B | Healthcare |
| 33 | AGOMAB THERAPEUTICS SA Private | — | 0.20% | $1.8M | 7,649 | — | — | — |
| 34 | AGOMAB THERAPEUTICS SA Private | — | 0.20% | $1.8M | 7,729 | — | — | — |
| 35 | PARAGON BIOSCIENCES EMALEX CAPITAL INC Private | — | 0.19% | $2.0M | 158,879 | — | — | — |
| 36 | ARRIVENT BIOPHARMA INC | AVBP | 0.19% | $2.0M | 107,000 | -5.3 | $1.0B | Healthcare |
| 37 | VIKING THERAPEUTICS INC | VKTX | 0.16% | $1.8M | 65,000 | -10.5 | $3.8B | Healthcare |
| 38 | SUMMIT THERAPEUTICS INC | SMMT | 0.16% | $1.7M | 73,517 | -12.4 | $13.4B | Healthcare |
| 39 | VIR BIOTECHNOLOGY INC | VIR | 0.13% | $1.4M | 280,800 | -2.9 | $1.4B | Healthcare |
| 40 | CASTLE CREEK BIOSCIENCES INC Private | — | 0.12% | $1.3M | 6,308 | — | — | — |
| 41 | EDGEWISE THERAPEUTICS INC | EWTX | 0.11% | $1.2M | 83,600 | -19.6 | $3.4B | Healthcare |
| 42 | EVOZYNE INC Private | — | 0.10% | $1.1M | 978,945 | — | — | — |
| 43 | EVOZYNE INC Private | — | 0.09% | $932,910 | 56,643 | — | — | — |
| 44 | PARAGON BIOSCIENCES EMALEX CAPITAL INC Private | — | 0.03% | $276,467 | 22,477 | — | — | — |
| 45 | PARAGON BIOSCIENCES EMALEX CAPITAL INC Private | — | 0.02% | $206,423 | 15,977 | — | — | — |
| 46 | EVOZYNE INC Private | — | 0.01% | $93,397 | 5,900 | — | — | — |
| 47 | PARAGON BIOSCIENCES EMALEX CAPITAL INC Private | — | 0.01% | $63,538 | 4,581 | — | — | — |
| 48 | CASTLE CREEK BIOSCIENCES INC Private | — | 0.00% | $46,866 | 200 | — | — | — |
| 49 | CASTLE CREEK BIOSCIENCES INC Private | — | 0.00% | $15,776 | 85 | — | — | — |
| 50 | LEAP THERAPEUTICS INC Private | — | 0.00% | $1 | 60,600 | — | — | — |